Johnson & Johnson invests in telehealth startup: 5 details

Thirty Madison has actually raised $70 million to date.
© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this material?

© Copyright ASC COMMUNICATIONS 2020. Intrigued in LINKING to or REPRINTING this content? View our policies by click on this link.

Johnson & & Johnson purchased telehealth start-up Thirty Madison, a digital health company concentrated on handling persistent conditions.
Five details:
1. Johnson & & Johnson Innovation joined Thirty Madisons Series B financing round which closed on $47 million Aug. 14. Thirty Madison has actually raised $70 million to date.
2. Polaris Partners led the funding round, and existing financiers Maveron and Northzone likewise got involved.
3. Thirty Madisons portfolio brands consist of:
· Keeps, which focuses on treating loss of hair · Cove, which deals with migraines · Evens, which treats heartburn
The business supply virtual visits, restorative treatments and educational tools for clients.
4. Thirty Madison said it prepares to further innovate in digital health care with the new financial investment round.
5. Johnson & & Johnson acknowledged a broader trend towards people seeking on-demand, personalized take care of persistent conditions with the financial investment, Fortune reported. Stacy Feld, the Johnson & & Johnson investment head of west North America, Australia and New Zealand, said the financial investment “aligns to our overall technique, which is to bring new healthcare products and options to individuals who need them most.”
More posts on telehealth: MDLive intends to go public in early 2021: 5 detailsRemote monitoring tech incites privacy, safety issues amongst bioethics activistsUniversity Hospital, Rutgers launch 7-day virtual urgent care